Search PubMedSearch

PubMed · 42607672

The Gabriella Miller Kids First Data Resource for genomic research in pediatric cancer and congenital anomalies.

Abstract

Nine-year-old brain tumor patient Gabriella Miller challenged members of Congress to "stop talking and start doing" when providing federal funding for research into cures for pediatric cancer and congenital anomalies. Though she ultimately lost her life to that cancer, her advocacy efforts resulted in the 2014 Gabriella Miller Kids First Research Act, launching the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health (NIH). The overarching goal of the Gabriella Miller Kids First Pediatric Research Program is to help researchers uncover new insights into the biology of childhood cancer and congenital anomalies. Following the signing of the Gabriella Miller Kids First Research Act 2.0 in January 2025, the program has been extended at NIH through 2028 to advance the groundwork laid in the program's first ten years. The Gabriella Miller Kids First Data Resource Center has since honored her legacy by building a comprehensive data resource for genomic research into pediatric conditions. Data from more than 30,000 participants annotated with demographic and clinical information related to their diagnoses have been released for secondary research and analysis using the center's web-based platforms. This paper analyzes the outcomes of the initiative and highlights breakthroughs made by the larger research community resulting from the availability of this data resource. We explore the future expansion of the data resource to include new modalities and tools for supporting life-saving research for children like Gabriella Miller.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David M Higgins, Christopher Blackden, Miguel Brown, Christina Diaz, Leslie Duffy, Christopher Friedman, Yiran Guo, Mateusz Koptyra, Qi Li, Alex Lubneuski, Dan Miller, Bobby Moulder, Wendy Payton, Emily Reed, Whitney Rife, Alex Sickler, Natasha Singh, Amanda Warkow, Eric Wenger, Jessica Wong, Bo Zhang, Chuwei Zhong, Yuankun Zhu, Gaelle Altefrohne, Denis Beauregard, Jeremy Costanza, Evans Girard, Luc-Frederic Langis, Lucas Lemonnier, Adrian Paul, Céline Pelletier, Karine St-Onge, Jean-Philippe Thibert, Michele Mattioni, Surya Saha, Jared Rozowsky, Milos Trboljevac, Marko Zecevic, Jeff Knight, Gina Kuffel, Radhika Reddy, Pauline Ribeyre, Bailey Farrow, Yelena Cox, Andrew Ericson, Jamed Ferreris Vargas, Sophie Forman, Sofia Labrecque, Eric Torstenson, Kai Yin Ho, Nicole A Vasilevsky, Emily Boja, Valerie Cotton, Danielle Daee, Marcia V Fournier, Jaime M Guidry Auvil, Andréa C Harris, Huiqing Li, Lu Wang, Brandi Davis-Dusenbery, Melissa A Haendel, Jena Lilly, Phillip B Storm, Sam Volchenboum, Robert L Grossman, Robert Carroll, Jack DiGiovanna, Deanne Taylor, Vincent Ferretti, Adam Resnick, Allison P Heath. 2026-08-17. The Gabriella Miller Kids First Data Resource for genomic research in pediatric cancer and congenital anomalies.. https://doi.org/10.1016/j.ajhg.2026.07.010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans